Archive

  • AXA IM Alts raises €1.9bn for European Life Sciences investments

    26 July 2021

    Following acquisition of boutique asset manager Kadans Science Partner

Cookies on Insurance Asset Risk

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here